Skip to content

D:A:D finding that abacavir and ddI increase heart attack risk 'incomplete' say FDA

Immune reconstitution seen in 10% of South Africans starting HIV treatment

Race and gender risk factors for some anti-HIV treatment side-effects

Genetics protect some against lipodystrophy caused by HIV drugs

Anti-inflammatory drug could reduce heart disease risk in patients with HIV

Revised US labelling for darunavir/ritonavir recommends caution for patients with liver problems

Evidence from large US cohort says anti-HIV therapy does not increase heart disease risk

French study further mystifies causes of bone loss in people with HIV

Gene associated with efavirenz and nevirapine rash identified